Deficiency of Kruppel-like factor KLF4 in myeloid-derived suppressor cells inhibits tumor pulmonary metastasis in mice accompanied by decreased fibrocytes

Oncogenesis

Volumn 3, Issue 11, 2014, Pages

  Shi, Y ^a,b   Ou, L ^b,c   Han, S ^c   Li, M ^c   Pena, M M O ^d   Pena, E A ^d   Liu, C ^e   Nagarkatti, M ^b   Fan, D ^b   Ai, W ^b  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d UNIVERSITY OF SOUTH CAROLINA   (United States)

^e UNIVERSITY OF KENTUCKY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALVASCULIN; KRUPPEL LIKE FACTOR 4;

ADOPTIVE TRANSFER; ANIMAL CELL; ARTICLE; BONE MARROW CELL; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL DIFFERENTIATION; CELL POPULATION; CONTROLLED STUDY; GENE EXPRESSION; IN VITRO STUDY; LUNG FIBROBLAST; LUNG METASTASIS; MELANOMA; MOUSE; MYELOID DERIVED SUPPRESSOR CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SUPPRESSOR CELL;

MUS;

EID: 84927727444     PISSN: None     EISSN: 21579024     Source Type: Journal    
DOI: 10.1038/oncsis.2014.44     Document Type: Article

References (29)

1. Manjili MH. Phenotypic plasticity of MDSC in cancers. Immunol Invest 2012; 41: 711-721.
2. Youn JI, Gabrilovich DI. The biology of myeloid-derived suppressor cells: the blessing and the curse of morphological and functional heterogeneity. Eur J Immunol 2010; 40: 2969-2975.
3. Saleem SJ, Martin RK, Morales JK, Sturgill JL, Gibb DR, Graham L et al. Cutting edge: mast cells critically augment myeloid-derived suppressor cell activity. J Immunol 2012; 189: 511-515.
4. Gabrilovich DI, Ostrand-Rosenberg S, Bronte V. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012; 12: 253-268.
5. Waldron TJ, Quatromoni JG, Karakasheva TA, Singhal S, Rustgi AK. Myeloid derived suppressor cells: targets for therapy. Oncoimmunology 2013; 2: e24117.
6. Niedermeier M, Reich B, Rodriguez Gomez M, Denzel A, Schmidbauer K, Gobel N et al. CD4+ T cells control the differentiation of Gr1+ monocytes into fibrocytes. Proc Natl Acad Sci USA 2009; 106: 17892-17897.
7. Hong KM, Belperio JA, Keane MP, Burdick MD, Strieter RM. Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-Activated receptor gamma. J Biol Chem 2007; 282: 22910-22920.
8. Mehner C, Radisky DC. Triggering the landslide: the tumor-promotional effects of myofibroblasts. Exp Cell Res 2013; 319: 1657-1662.
9. Kraman M, Bambrough PJ, Arnold JN, Roberts EW, Magiera L, Jones JO et al. Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-Alpha. Science 2010; 330: 827-830.
10. Zhang H, Maric I, Diprima MJ, Khan J, Orentas RJ, Kaplan RN et al. Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer. Blood 2013; 122: 1105-1113.
11. van Deventer HW, Palmieri DA, Wu QP, McCook EC, Serody JS. Circulating fibrocytes prepare the lung for cancer metastasis by recruiting Ly-6C+ monocytes via CCL2. J Immunol 2013; 190: 4861-4867.
12. Shields JM, Christy RJ, Yang VW. Identification and characterization of a gene encoding a gut-enriched Kruppel-like factor expressed during growth arrest. J Biol Chem 1996; 271: 20009-20017.
13. Feinberg MW, Wara AK, Cao Z, Lebedeva MA, Rosenbauer F, Iwasaki H et al. The Kruppel-like factor KLF4 is a critical regulator of monocyte differentiation. Embo J 2007; 26: 4138-4148.
14. Pandya AY, Talley LI, Frost AR, Fitzgerald TJ, Trivedi V, Chakravarthy M et al. Nuclear localization of KLF4 is associated with an aggressive phenotype in earlystage breast cancer. Clin Cancer Res 2004; 10: 2709-2719.
15. Yu F, Li J, Chen H, Fu J, Ray S, Huang S et al. Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene 2011; 30: 2161-2172.
16. Yu F, Shi Y, Wang J, Li J, Fan D, Ai W. Deficiency of Kruppel-like factor KLF4 in mammary tumor cells inhibits tumor growth and pulmonary metastasis and is accompanied by compromised recruitment of myeloid-derived suppressor cells. Int J Cancer 2013; 133: 2872-2883.
17. Schreiber RD, Old LJ, Smyth MJ. Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion. Science 2011; 331: 1565-1570.
18. Qian BZ, Li J, Zhang H, Kitamura T, Zhang J, Campion LR et al. CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis. Nature 2011; 475: 222-225.
19. Qu P, Boelte KC, Lin PC. Negative regulation of myeloid-derived suppressor cells in cancer. Immunol Invest 2012; 41: 562-580.
20. Reilkoff RA, Bucala R, Herzog EL. Fibrocytes: emerging effector cells in chronic inflammation. Nat Rev Immunol 2011; 11: 427-435.
21. Phillips RJ, Burdick MD, Hong K, Lutz MA, Murray LA, Xue YY et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004; 114: 438-446.
22. Otranto M, Sarrazy V, Bonte F, Hinz B, Gabbiani G, Desmouliere A. The role of the myofibroblast in tumor stroma remodeling. Cell Adh Migr 2012; 6: 203-219.
23. Crawford JR, Pilling D, Gomer RH. Improved serum-free culture conditions for spleen-derived murine fibrocytes. J Immunol Methods 2010; 363: 9-20.
24. Helfman DM, Kim EJ, Lukanidin E, Grigorian M. The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer 2005; 92: 1955-1958.
25. Mishra SK, Siddique HR, Saleem M. S100A4 calcium-binding protein is key player in tumor progression and metastasis: preclinical and clinical evidence. Cancer Metastasis Rev 2012; 31: 163-172.
26. Cabezon T, Celis JE, Skibshoj I, Klingelhofer J, Grigorian M, Gromov P et al. Expression of S100A4 by a variety of cell types present in the tumor microenvironment of human breast cancer. Int J Cancer 2007; 121: 1433-1444.
27. Alder JK, Georgantas RW 3rd, Hildreth RL, Kaplan IM, Morisot S, Yu X et al. Kruppellike factor 4 is essential for inflammatory monocyte differentiation in vivo. J Immunol 2008; 180: 5645-5652.
28. Real PJ, Tosello V, Palomero T, Castillo M, Hernando E, de Stanchina E et al. Gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia. Nat Med 2009; 15: 50-58.
29. Zhang W, Chen X, Kato Y, Evans PM, Yuan S, Yang J et al. Novel cross talk of Kruppel-like factor 4 and beta-catenin regulates normal intestinal homeostasis and tumor repression. Mol Cell Biol 2006; 26: 2055-2064.